Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bolt Biotherapeutics Inc BOLT

Healthcare Biotechnology
Bolt Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer. The Company's pipeline candidates are built on its expertise in myeloid biology and cancer drug development. Its pipeline includes trastuzumab imbotolimod (formerly BDC-1001), a human epidermal growth factor receptor 2 - targeting Boltbody Immune-Stimulating... see more

Recent & Breaking News (NDAQ:BOLT)

BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Bolt Biotherapeutics, Inc. to Contact the Firm Today!

Accesswire August 18, 2024

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Newsfile August 18, 2024

The Schall Law Firm Invites Shareholders To Participate In Securities Fraud Lawsuit Against Bolt Biotherapeutics Inc

Accesswire August 17, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BOLT

PR Newswire August 17, 2024

BOLT Investors Have Opportunity to lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit

PR Newswire August 16, 2024

BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Newsfile August 16, 2024

The Schall Law Firm Seeks Shareholders To Lead Securities Fraud Lawsuit Against Bolt Biotherapeutics Inc

Accesswire August 16, 2024

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Newsfile August 16, 2024

BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Shareholders of Bolt Biotherapeutics, Inc. to Contact the Firm Today!

Accesswire August 16, 2024

Investors Encouraged To Join In The Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit With The Schall Law Firm

Accesswire August 15, 2024

BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

Newsfile August 15, 2024

BOLT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Bolt Biotherapeutics, Inc. to Contact the Firm Today!

Accesswire August 15, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Bolt Biotherapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - BOLT

Accesswire August 15, 2024

Investors Can Take The Lead In The Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit With The Schall Law Firm

Accesswire August 14, 2024

BOLT Investors Have the Opportunity to Lead Bolt Biotherapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm

PR Newswire August 14, 2024

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

PR Newswire August 14, 2024

BOLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Bolt Biotherapeutics, Inc. Shareholders to Actively Participate in Class Action Lawsuit!

Accesswire August 14, 2024

The Schall Law Firm Invites Investors To Lead The Securities Fraud Lawsuit Against Bolt Biotherapeutics Inc

Accesswire August 13, 2024

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire August 13, 2024

BOLT SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Bolt Biotherapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

Accesswire August 13, 2024